Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)
NCT07375966
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
198
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Stroke
Interventions
DRUG:
Tenecteplase
Sponsor
General Hospital of Shenyang Military Region